Pharminent

Roche Forms Global Immunotherapy R&D Network

NewsRoche will invest up to 100 million Swiss Francs to support basic and clinical research collaborations related to cancer immunotherapy.Topics: Biotech http://www.dddmag.com/news/2016/11/roche-forms-global-immunotherapy-r-d-network

Filed under: Cancer, Immunotherapy